Related references
Note: Only part of the references are listed.The Role of Adipose Tissue and Lipotoxicity in the Pathogenesis of Type 2 Diabetes
Kenneth Cusi
CURRENT DIABETES REPORTS (2010)
Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes:: a multicentre randomised parallel-group trial
Jianping Weng et al.
LANCET (2008)
Islet β cell failure in type 2 diabetes
Marc Prentki et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study
H. C. Gerstein et al.
DIABETIC MEDICINE (2006)
Psychological insulin resistance in patients with type 2 diabetes - The scope of the problem
WH Polonsky et al.
DIABETES CARE (2005)
Type 2 diabetes, insulin secretion and β-cell mass
B Ahrén
CURRENT MOLECULAR MEDICINE (2005)
Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of β-cell function
YB Li et al.
DIABETES CARE (2004)
Short-term intensive insulin therapy in newly diagnosed type 2 diabetes
EA Ryan et al.
DIABETES CARE (2004)
[LysB3, GluB29] insulin:: a novel insulin analog with enhanced β-cell protective action
I Rakatzi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects
T Tsunekawa et al.
DIABETES CARE (2003)
Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes
PE Cryer
DIABETOLOGIA (2002)
Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects:: Evidence for an anti-inflammatory effect?
P Dandona et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function
SI McFarlane et al.
DIABETIC MEDICINE (2001)
Share Paper
